The Alabama Department of Public Health (ADPH) has received an advisory from the Centers for Disease Control & Prevention (CDC), that monoclonal antibodies to treat COVID-19 are again being shipped to states, effective immediately.
On December 23rd, the U.S. Department of Health & Human Services had announced the temporary pause in allocations of some monoclonal antibodies.
Various therapeutics are available for preventing and treating COVID-19 in specific at-risk populations. Some therapeutics are in short supply – however, the availability is expected to increase in the coming months. The ADPH is reminding the public that vaccines remain the best preventive measure against severe disease, hospitalizations and death, due to COVID-19, for all those that are eligible to receive dosages. Most persons being hospitalized for COVID-19 continue to be individuals who are not vaccinated or are only partially vaccinated.
For more information on COVID-19, go to www.alabamapublichealth.gov.